First Page | Document Content | |
---|---|---|
![]() Date: 2010-10-05 09:53:16Finasteride Benign prostatic hyperplasia 5-alpha-reductase inhibitor Transurethral resection of the prostate Prostate cancer Urinary retention Testosterone Dihydrotestosterone Merck & Co. Medicine Lactams Androgens | Add to Reading List |
![]() | https://www.ebudata.com/ebu/host_centre_applic_form/print_hc_blDocID: 1pdaO - View Document |
![]() | [FIRSTST/NEWSDESK/PAGE<HOM-007> ...DocID: 19DZI - View Document |
![]() | 1 Prostate artery embolisation The following information about prostate artery embolisation (PAE) explains what is involved and the possible risks. It is not meant to be a substitute for informed discussion between youDocID: 1784d - View Document |
![]() | One Gustave L. Levy Place, Box 1272, New York, NYTHE DEANE CENTER Mount Sinai School of Medicine Finding Relief for BPH Continued from page 1DocID: 12Zo3 - View Document |
![]() | WINTER 2008 The Barbara and Maurice Deane Prostate Health and Research CenterDocID: 122bU - View Document |